BN9The Bank of New York Mellon Corporation

🇩🇪 Xetra
135.00
EUR
Analysis Scores
Lothien Robustness Score?
66/100
Strong
Neden bu skor?
Damodaran ?
47/100
ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır
Dalio Risk ?
88/100
Piotroski ?
2/9
Weak
Previous period ROA data missing (C1 delta-ROA); Total assets data missing → ROA cannot be calculated (C2); Önceki yıl borç/varlık verisi yok → kaldıraç azalması kontrol edilemedi (C5); Current ratio data missing (C6); gross profit data missing → margin comparison unavailable (C8); current assets data missing → turnover calculation unavailable (C9); Banka/finans: kaldıraç/cari-oran/marj kriterleri uygulanamaz, skor kalan kriterlere göre normalize edildi
Graham ?
Veri Yetersiz
Özkaynaklar negatif veya sıfır — Graham formülü pozitif defter değeri gerektirir
Active Metric?
3/4
Confidence?
64%
Lothien Robustness Summary
63/100
Lothien Sağlamlık: Güçlü (63/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 2 | Negatif: 0 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte €1.6B net kâr açıklandı. Şirket kârlı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%+8.3). İstikrarlı seyir.
5 Çeyrek Üst Üste Artış
Son 5 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.

Data date 2026-11-19 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-11-19
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Orta
252 days
Annual Volatility ?
%26.9
VaR 95% ?
%2.62
daily max loss
VaR 99% ?
%3.78
daily max loss
CVaR 95% ?
%3.86
expected loss (tail)
Max Drawdown ?
%14.6
24.07.2026 → 14.10.2026
Skewness ?
0.17
Parametrik%2.62
Historik%2.28
Cornish-Fisher%2.38
Return Distribution
Valuation
Potential?
+4.5%
DCF Value ?
109.66
Debt Cycle?
Geç Genişleme
Balance Sheet Analysis? Q2026/9
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 üzerinde: %+7.5 — teknik trend olumlu
Destek seviyesi: TRAMA-99 = 125.62 EUR
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %10.9
ROE %10.9 — moderate return on equity.
Free Cash Flow Margin (TTM) %7.1
TTM Free Cash Flow is %7.1'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio 16.4x Sector: 15.9x
F/K 16.4x — sector median's (15.9x) %3 above. Slight premium.
P/B Ratio 2.30x Sector: 2.97x
PD/DD 2.30x — sector median (2.97x) below or near. Reasonable valuation.
Indebtedness
Debt / Equity 0.75x
Debt/Equity 0.75x — moderate financial leverage.
Growth
Revenue Growth (YoY) %+13.8
Revenue YoY %13.8 grew — healthy growth rate.
Net Profit Growth (YoY) %+24.2
Net profit YoY %24.2 increased — strong profit growth.
Score Explanations
Lothien Robustness
66/100
Good robustness (66/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+4.5%
Plus %4.5 expected value (141.10) vs current price comparison. 3/4 valuation models could be calculated. Model confidence %64.
Components: PE target: 137.42 | P/B target: 180.98 | DCF target: 109.66
Damodaran Valuation
47/100
Moderate
Dalio Risk Analysis
88/100
Low debt risk (88/100).
Leverage: 50/100 | Debt Service: 50/100 | Quality: 88/100
DCF Discounted Cash Flow
109.66
DCF (109.66) current price %18.8 below — cash flows do not support current price.
Current price: 135.00
Debt Cycle Phase
Geç Genişleme
Piotroski F-Score
2/9
Weak Piotroski (2/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Total assets data missing → ROA cannot be calculated (C2)
Weak
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
16.4x vs 15.9x
Sector median's %3 above — expensive
P/B Ratio
2.30x vs 2.97x
Compared to sector %22 cheaper (by book value)
TRAMA-99 Trend — Uptrend
Price (135.00), TRAMA-99 line's %7.5 above. Uptrend ongoing; monitor for TRAMA approach for trend change.
Price:: 135.00
TRAMA: 125.62
Difference: %+7.5
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
BN9 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.